1Y Close · As of Aug 26, 2026
BCWORLDPHARM operates in the Pharmaceuticals sector.
Legal name: BCWORLDPHARM Co., Ltd.
In fiscal year 2025, BCWORLDPHARM (200780) reported revenue of 75.8 billion KRW, up 1.3% from 74.8 billion KRW a year earlier.
Operating profit was 2.0 billion KRW and net income was -3.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 32.5 billion KRW, with a P/B of 0.45.
These figures can be verified in the DART filing (receipt no. 20260313001254).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 75.8B | 2.0B | -3.1B |
| 2024 | 74.8B | 1.5B | -3.3B |
| 2023 | 75.1B | 6.4B | 2.9B |
| 2022 | 72.7B | 1.9B | 60M |
| 2021 | 62.1B | -1.8B | -2.2B |
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-13 | Semi-Annual Report (2026.06) |
| 2026-08-04 | Large Shareholding Report (General) |